Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,223 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $9.32, for a total transaction of $207,118.36. The transaction was disclosed in a legal filing with the SEC, which […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) CFO Robert Andrade sold 10,000 shares of Fennec Pharmaceuticals stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $8.99, for a total transaction of $89,900.00. Following the completion of the transaction, the chief financial officer now owns 139,721 shares in […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,720,000 shares, an increase of 17.0% from the May 15th total of 1,470,000 shares. Approximately 7.9% of the shares of the stock are sold […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) Director Chris A. Rallis sold 1,758 shares of the firm’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $7.36, for a total transaction of $12,938.88. Following the sale, the director now owns 31,033 shares of the company’s stock, valued […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) had its price target increased by Cantor Fitzgerald from $12.00 to $16.00 in a research note issued to investors on Thursday, The Fly reports. They currently have an overweight rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $18.00 target price on shares of […]